Concepedia

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

G.P. Murphy, B.A. Tjoa, S.J. Simmons, Justin Jarisch, Victoria Bowes, Haakon Ragde, M. Rogers, A. Elgamal, Gerald M. Kenny, Oliver E. Cobb,

The Prostate · 1999 · 240 citations · 8 references

DOI

Abstract

Over 30% of study participants in this group showed a positive response at the conclusion of the trial. This study suggested that DC-based cancer vaccines may provide an alternative therapy for prostate cancer patients whose disease no longer responds to hormone therapy.

References

8

Cancer statistics, 1998

Sarah Landis, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 1998 · 2.4K citations · Full text

, , +10

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

G.P. Murphy, B.A. Tjoa, Haakon Ragde et al. · The Prostate · 1996 · 395 citations

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

B.A. Tjoa, S.J. Simmons, Victoria Bowes et al. · The Prostate · 1998 · 243 citations

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

B.A. Tjoa, Sheila J. Erickson, Victoria Bowes et al. · The Prostate · 1997 · 127 citations · Full text

Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990.

Jones Gw, Curtis Mettlin, Murphy Gp et al. · PubMed · 1995 · 80 citations